BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○
BiohacksAI/Compounds/Dihydroergocryptine/Similar

Compounds Similar to Dihydroergocryptine

10 compounds with shared biological targets · BiohacksAI corpus current

The compounds below share molecular targets and biological mechanisms with Dihydroergocryptine, including interactions with ADRA1A, ADRA2A, DRD1. Similarity is calculated using target-weighted Jaccard scoring across the BiohacksAI BindingDB corpus. Higher shared target counts indicate stronger mechanistic overlap.

View Dihydroergocryptine profile →DOPAMINE SEROTONIN pathwayTESTOSTERONE HORMONES pathway
Similar Compounds — Ranked by Target Overlap
1
bp
5
shared
56%
overlap
2
Penbutolol
4
shared
246
studies
55%
overlap
3
fauc
3
shared
38%
overlap
4
Dihydroergocornine
5
shared
65
studies
37%
overlap
5
Indoramin
4
shared
250
studies
34%
overlap
6
Oxyfedrine
4
shared
144
studies
34%
overlap
7
Phenylephrine
5
shared
299
studies
33%
overlap
8
mazapertine
3
shared
31%
overlap
9
ropinirole
3
shared
29%
overlap
10
rauwolscine
3
shared
29%
overlap
Shared Biological Targets
HTR1AADRA1AADRA2ADRD3SLC6A45-HYDROXYTRYPTAMINEADRA2BADRA2C

Click a target to see all compounds with interactions at that molecular target.

Similarity between compounds is computed using IDF-weighted Jaccard scoring across shared molecular targets in the BiohacksAI BindingDB corpus. Compounds with higher overlap scores share more targets, weighted by how specific those targets are across the entire corpus.

Explore related resources: Dihydroergocryptine full profile · Browse all compounds · Biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.